Indeed, EVs have been shown to deliver KRAS siRNA to inhibit the growth of lung cancer [51], while the transfer of anti-miR21 oligonucleotides via modified EVs has been found to suppress tumor growth in glioblastoma [52]. Here, KRAS is linked to lung carcinoma.